|
STK17B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.568200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.406000E-02 |
| Normal-vs-Stage2 |
5.408600E-01 |
| Normal-vs-Stage3 |
7.336800E-01 |
| Normal-vs-Stage4 |
5.666200E-01 |
| Stage1-vs-Stage2 |
3.912400E-01 |
| Stage1-vs-Stage3 |
1.957800E-01 |
| Stage1-vs-Stage4 |
5.572200E-01 |
| Stage2-vs-Stage3 |
8.053400E-01 |
| Stage2-vs-Stage4 |
9.550600E-01 |
| Stage3-vs-Stage4 |
8.000400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.239700E-02 |
| Normal-vs-AfricanAmerican |
3.080400E-01 |
| Normal-vs-Asian |
2.980400E-01 |
| Caucasian-vs-AfricanAmerican |
2.888800E-01 |
| Caucasian-vs-Asian |
9.097600E-01 |
| AfricanAmerican-vs-Asian |
6.487000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.178700E-03 |
| Normal-vs-Female |
9.282400E-01 |
| Male-vs-Female |
1.221720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.547180E-01 |
| Normal-vs-Extreme_Weight |
1.436250E-02 |
| Normal-vs-Obese |
4.794400E-01 |
| Normal-vs-Extreme_Obese |
2.234000E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.228800E-01 |
| Normal_Weight-vs-Obese |
3.413600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.200300E-02 |
| Extreme_Weight-vs-Obese |
5.635900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.563700E-02 |
| Obese-vs-Extreme_Obese |
4.158200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.036200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.434200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.703000E-03 |
| Normal-vs-Age(81-100Yrs) |
8.737500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.534400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.657620E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.360010E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.007560E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.020400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.595800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.101100E-03 |
| Normal-VS-Type2 PRCC |
1.205830E-01 |
| Normal-VS-KIRP CIMP |
9.570000E-02 |
| Normal-VS-Unclassified PRCC |
5.273200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.070400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.650140E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.839000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.219510E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.800100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.749400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.481700E-02 |
| Normal-vs-N1 |
7.150800E-01 |
| Normal-vs-N2 |
6.981800E-01 |
| N0-vs-N1 |
2.755900E-02 |
| N0-vs-N2 |
5.830600E-01 |
| N1-vs-N2 |
6.271400E-01 |
|
|
